Efficacy and Safety of 2 Doses of OnabotulinumtoxinA for the Treatment of Masseter Muscle Prominence: 6-Month Results From a Randomized, Phase 2b Placebo-Controlled Study. (July 2022)

Record Type:: Journal Article
Title:: Efficacy and Safety of 2 Doses of OnabotulinumtoxinA for the Treatment of Masseter Muscle Prominence: 6-Month Results From a Randomized, Phase 2b Placebo-Controlled Study. (July 2022)
Main Title:: Efficacy and Safety of 2 Doses of OnabotulinumtoxinA for the Treatment of Masseter Muscle Prominence: 6-Month Results From a Randomized, Phase 2b Placebo-Controlled Study
Authors:: Fabi, Sabrina
Jones, Derek
Biesman, Brian
Rivkin, Alexander
Garcia, Julia K.
Brandstetter, Tanya
Pan, Grace
Bowen, Beta
Lee, Elisabeth
Brin, Mitchell F.
Abstract:
Is Part Of:: Toxicon. Volume 214(2022)Supplement 1
Journal:: Toxicon
Issue:: Volume 214(2022)Supplement 1
Issue Display:: Volume 214, Issue 1 (2022)
Year:: 2022
Volume:: 214
Issue:: 1
Issue Sort Value:: 2022-0214-0001-0000
Page Start:: S60
Page End:
Publication Date:: 2022-07
Subjects:: Toxins -- Periodicals
Venom -- Periodicals
615.9
Journal URLs:: http://www.sciencedirect.com/science/journal/00410101 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/j.toxicon.2022.05.018 ↗
Languages:: English
ISSNs:: 0041-0101
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 8873.050000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 22758.xml